Anterix (ATEX) Asset Writedowns and Impairment (2018 - 2022)

Anterix has reported Asset Writedowns and Impairment for 5 years, with the latest figure at $127000.0 in Q1 2022.

• For the quarter ending Q1 2022, Asset Writedowns and Impairment rose 182.22% year-over-year to $127000.0; the trailing twelve-month figure through Dec 2021 stood at -$82000.0 (down 254.72% YoY), and the FY2021 full-year result was $85000.0, up 84.78% from the prior year.
• Asset Writedowns and Impairment for Q1 2022 stood at $127000.0, up from -$254000.0 in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $534000.0 in Q2 2018, with the low at -$254000.0 in Q4 2021.
• Historically, Asset Writedowns and Impairment has averaged $70307.7 across 5 years, with a median of $33000.0 in 2019.
• The largest YoY upside for Asset Writedowns and Impairment was 246.15% in 2021 against a maximum downside of 2409.09% in 2021.
• Anterix's Asset Writedowns and Impairment stood at $200000.0 in 2018, then sank by 83.5% to $33000.0 in 2019, then slumped by 66.67% to $11000.0 in 2020, then tumbled by 2409.09% to -$254000.0 in 2021, then soared by 150.0% to $127000.0 in 2022.
• The last three Asset Writedowns and Impairment figures came in at $127000.0 (Q1 2022), -$254000.0 (Q4 2021), and $112000.0 (Q3 2021), per Business Quant data.